- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02533986
Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects
February 10, 2016 updated by: Elin Östman, Lund University
The main objective of this study is to investigate the effect of a 4-weeks intake of berry peel powder on fasting and postprandial glucose metabolism and inflammatory markers.
The berry peel product will be compared with a placebo in a single-blind, cross-over design.
Furthermore, inflammation-related peripheral blood mononuclear cells (PBMCs) genes expression, appetite and cognitive performance will be included as a pilot study.
Investigators hypothesize that long-term consumption of polyphenols and fibres of berry peel will exhibit both direct and indirect actions in healthy overweight subjects by improvement of glucose-associated markers as well as ameliorating inflammation.
Moreover, above metabolic markers will correlated with improvements in inflammation-related PBMCs genes expression, subjective appetite and cognitive performance after long-term consumption of berry peel as a source of polyphenols.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Skåne
-
Lund, Skåne, Sweden, 221 00
- Food for Health Science Centre (Medicon Village) - Lund University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy males and females
- Signed informed consent
- BMI 25-30 kg/m2
- Must be able to accept plant-based foods/drinks
Exclusion Criteria:
- Below 18 years or above 40 years
- Smoking or using snuff
- vegetarian or vegan
- Stressed by venous blood sampling or previous experience of being difficult canulation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control drink
Dietary supplement: Control drink As control, subjects are asked to consume 150 ml control drink containing equal amount of insoluble fiber (cellulose) and sugar for 28 days.
In addition, on days-1 and 28, subjects will receive an acute challenge of placebo drink at our clinical facility.
After 30 min.
control drink intake, subjects will be given standardized breakfast corresponding to 50 g available carbohydrates.
|
|
Experimental: Berry peel drink
Dietary supplement: Berry peel drink Subjects are asked to consume 150 ml experimental drink containing a berry peel fruit powder.
In addition, on days-1 and 28, subjects will receive an acute challenge of test drink at our clinical facility.
After 30 min.
berry drink intake, subjects will be given standardized breakfast corresponding to 50 g available carbohydrates.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial blood glucose response after acute intervention
Time Frame: -30, 0, 15, 30, 45, 60, 120, and 180 min after challenge meal.
|
The capillary blood will be collected for glucose analysis using a glucometer.
|
-30, 0, 15, 30, 45, 60, 120, and 180 min after challenge meal.
|
Incremental area under curve (iAUC) blood glucose response after long-term intervention
Time Frame: 4 weeks
|
The capillary blood will be collected for glucose analysis using a glucometer.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial serum insulin response after acute intervention
Time Frame: -30, 0, 15, 30, 45, 60, 120, and 180 min.
|
The capillary blood will be collected for insulin analysis using commercial ELISA kits
|
-30, 0, 15, 30, 45, 60, 120, and 180 min.
|
Incremental area under curve (iAUC) serum insulin response after long-term intervention
Time Frame: 4 weeks
|
The capillary blood will be collected for insulin analysis using commercial ELISA kits
|
4 weeks
|
Postprandial subjective appetite rating after acute intervention
Time Frame: -30, 0, 15, 30, 45, 60, 120, and 180 min.
|
Appetite will be assessed using standard subjective 100mm visual analogue scaled (VAS).
|
-30, 0, 15, 30, 45, 60, 120, and 180 min.
|
Incremental area under curve (iAUC) subjective appetite rating after long-term intervention
Time Frame: 4 weeks
|
Appetite will be assessed using standard subjective 100mm visual analogue scaled (VAS).
|
4 weeks
|
Postprandial C-reactive protein (CRP) after acute intervention
Time Frame: -30, 60, 120, and 180 min.
|
The venous blood will be collected for CRP analysis using ELISA commercial kits
|
-30, 60, 120, and 180 min.
|
Incremental area under curve (iAUC) of C-reactive protein (CRP) after long-term intervention
Time Frame: 4 weeks
|
The venous blood will be collected for inflammatory analysis using ELISA commercial kits
|
4 weeks
|
Postprandial adiponectin after acute intervention
Time Frame: -30, 0, 60, 120, and 180 min.
|
The venous blood will be collected for adiponectin analysis using ELISA commercial kits
|
-30, 0, 60, 120, and 180 min.
|
Postprandial adiponectin after long-term intervention with berry peel
Time Frame: 4 weeks
|
The venous blood will be collected for adiponectin analysis using ELISA commercial kits
|
4 weeks
|
Peripheral blood mononuclear cells (PBMCs) inflammatory genes expression after acute intervention
Time Frame: 180 min after challenge meal.
|
The venous blood samples will be taken for isolation of peripheral blood mononuclear cells (PBMCs).
Extracted total RNA will then be used for running quantitative-PCR.
|
180 min after challenge meal.
|
Peripheral blood mononuclear cells (PBMCs) inflammatory genes expression after long-term intervention
Time Frame: -30 min. (Day-28 control); 180 min. (Day-28 control); -30 min. (Day-28 berry); 180 min. (Day-28 berry)
|
The venous blood samples will be taken for isolation of peripheral blood mononuclear cells (PBMCs).
Extracted total RNA will then be used for running quantitative-PCR.
|
-30 min. (Day-28 control); 180 min. (Day-28 control); -30 min. (Day-28 berry); 180 min. (Day-28 berry)
|
Postprandial selective attention after long-term intervention
Time Frame: 45, 90, and 180 min after challenge meal.
|
The selective attention will be assessed using a standardized software (Röd and Grön software) that measures wrong/right decisions and time of reaction when the subjects is faced with a challenging stimulus.
|
45, 90, and 180 min after challenge meal.
|
Postprandial interleukin-6 (IL-6) after acute intervention
Time Frame: -30, 60, 120, and 180 min.
|
The venous blood will be collected for IL-6 analysis using ELISA commercial kits
|
-30, 60, 120, and 180 min.
|
Incremental area under curve (iAUC) of interleukin-6 (IL-6) after long-term intervention
Time Frame: 4 weeks
|
The venous blood will be collected for IL-6 analysis using ELISA commercial kits
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Yoghatama Cindya Zanzer, MSc, Lund University
- Study Chair: Angela G Batista, MSc, Lund University; University of Campinas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
August 20, 2015
First Submitted That Met QC Criteria
August 24, 2015
First Posted (Estimate)
August 27, 2015
Study Record Updates
Last Update Posted (Estimate)
February 11, 2016
Last Update Submitted That Met QC Criteria
February 10, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- COGBERRY-BR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Control drink
-
Mondelēz International, Inc.Reading Scientific Services Ltd.CompletedGlycaemic Index | Glycaemic ResponseUnited Kingdom
-
Northumbria UniversityThe New Zealand Institute for Plant and Food ResearchCompletedAgeingUnited Kingdom
-
Per Bendix JeppesenFuture Food InnovationRecruiting
-
Northumbria UniversityThe New Zealand Institute for Plant and Food ResearchCompleted
-
Charite University, Berlin, GermanyCompletedHealthy | AgedGermany
-
David Grant U.S. Air Force Medical CenterCompletedQTc IntervalUnited States
-
Abbott NutritionActive, not recruiting
-
Abbott NutritionTerminatedRespiratory Infections in ChildrenUnited States
-
Hacettepe UniversityAnkara UniversityCompletedBody Weight | Appetite | Dietary IntakeTurkey